nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—Cerebrovascular disorder—Ramipril—type 1 diabetes mellitus	0.0181	0.0333	CcSEcCtD
Sertraline—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.0167	0.133	CbGeAlD
Sertraline—Maprotiline—CHRM2—type 1 diabetes mellitus	0.014	1	CrCbGaD
Sertraline—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.0139	0.0257	CcSEcCtD
Sertraline—Digestion impaired—Ramipril—type 1 diabetes mellitus	0.0121	0.0223	CcSEcCtD
Sertraline—SLC6A3—nerve—type 1 diabetes mellitus	0.0117	0.0926	CbGeAlD
Sertraline—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.0108	0.02	CcSEcCtD
Sertraline—MAOB—nerve—type 1 diabetes mellitus	0.0101	0.0807	CbGeAlD
Sertraline—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00976	0.018	CcSEcCtD
Sertraline—SLC6A2—nerve—type 1 diabetes mellitus	0.0094	0.0747	CbGeAlD
Sertraline—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00934	0.0172	CcSEcCtD
Sertraline—Glossitis—Ramipril—type 1 diabetes mellitus	0.00878	0.0162	CcSEcCtD
Sertraline—MAOA—nerve—type 1 diabetes mellitus	0.00866	0.0689	CbGeAlD
Sertraline—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00829	0.0153	CcSEcCtD
Sertraline—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00786	0.0145	CcSEcCtD
Sertraline—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00736	0.0135	CcSEcCtD
Sertraline—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00732	0.0135	CcSEcCtD
Sertraline—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00724	0.0133	CcSEcCtD
Sertraline—Polyuria—Ramipril—type 1 diabetes mellitus	0.00669	0.0123	CcSEcCtD
Sertraline—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00669	0.0123	CcSEcCtD
Sertraline—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00663	0.0122	CcSEcCtD
Sertraline—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00657	0.0121	CcSEcCtD
Sertraline—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00654	0.012	CcSEcCtD
Sertraline—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00636	0.0117	CcSEcCtD
Sertraline—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00634	0.0117	CcSEcCtD
Sertraline—Amnesia—Ramipril—type 1 diabetes mellitus	0.00625	0.0115	CcSEcCtD
Sertraline—Purpura—Ramipril—type 1 diabetes mellitus	0.0061	0.0112	CcSEcCtD
Sertraline—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00607	0.0112	CcSEcCtD
Sertraline—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00602	0.0111	CcSEcCtD
Sertraline—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.0059	0.0109	CcSEcCtD
Sertraline—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00583	0.0107	CcSEcCtD
Sertraline—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00537	0.00988	CcSEcCtD
Sertraline—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00531	0.00978	CcSEcCtD
Sertraline—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00529	0.00974	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00529	0.00974	CcSEcCtD
Sertraline—Gastritis—Ramipril—type 1 diabetes mellitus	0.0052	0.00958	CcSEcCtD
Sertraline—SIGMAR1—islet of Langerhans—type 1 diabetes mellitus	0.00514	0.0408	CbGeAlD
Sertraline—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00508	0.00935	CcSEcCtD
Sertraline—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00499	0.0092	CcSEcCtD
Sertraline—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00498	0.00917	CcSEcCtD
Sertraline—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00495	0.00911	CcSEcCtD
Sertraline—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00488	0.00899	CcSEcCtD
Sertraline—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00482	0.00888	CcSEcCtD
Sertraline—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00472	0.00869	CcSEcCtD
Sertraline—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00468	0.00861	CcSEcCtD
Sertraline—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00463	0.00854	CcSEcCtD
Sertraline—Weight increased—Ramipril—type 1 diabetes mellitus	0.00462	0.00851	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00449	0.00827	CcSEcCtD
Sertraline—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00446	0.00822	CcSEcCtD
Sertraline—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00444	0.00817	CcSEcCtD
Sertraline—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00444	0.00817	CcSEcCtD
Sertraline—Jaundice—Ramipril—type 1 diabetes mellitus	0.00441	0.00813	CcSEcCtD
Sertraline—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00441	0.00813	CcSEcCtD
Sertraline—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.0044	0.00811	CcSEcCtD
Sertraline—Sweating—Ramipril—type 1 diabetes mellitus	0.00434	0.00799	CcSEcCtD
Sertraline—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00428	0.00789	CcSEcCtD
Sertraline—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00427	0.00787	CcSEcCtD
Sertraline—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00425	0.00782	CcSEcCtD
Sertraline—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00422	0.00778	CcSEcCtD
Sertraline—MAOA—islet of Langerhans—type 1 diabetes mellitus	0.00419	0.0334	CbGeAlD
Sertraline—SIGMAR1—nephron tubule—type 1 diabetes mellitus	0.00414	0.0329	CbGeAlD
Sertraline—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00406	0.00749	CcSEcCtD
Sertraline—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.004	0.00737	CcSEcCtD
Sertraline—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00399	0.00736	CcSEcCtD
Sertraline—MAOB—nephron tubule—type 1 diabetes mellitus	0.00396	0.0315	CbGeAlD
Sertraline—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00392	0.00721	CcSEcCtD
Sertraline—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00384	0.00708	CcSEcCtD
Sertraline—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00379	0.00698	CcSEcCtD
Sertraline—Flushing—Ramipril—type 1 diabetes mellitus	0.00377	0.00695	CcSEcCtD
Sertraline—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00367	0.00676	CcSEcCtD
Sertraline—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00366	0.00675	CcSEcCtD
Sertraline—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00363	0.00669	CcSEcCtD
Sertraline—SIGMAR1—pancreas—type 1 diabetes mellitus	0.00361	0.0287	CbGeAlD
Sertraline—Alopecia—Ramipril—type 1 diabetes mellitus	0.00359	0.00662	CcSEcCtD
Sertraline—MAOA—retina—type 1 diabetes mellitus	0.00359	0.0285	CbGeAlD
Sertraline—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00356	0.00656	CcSEcCtD
Sertraline—MAOB—cardiovascular system—type 1 diabetes mellitus	0.00356	0.0283	CbGeAlD
Sertraline—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00354	0.00652	CcSEcCtD
Sertraline—Erythema—Ramipril—type 1 diabetes mellitus	0.00354	0.00652	CcSEcCtD
Sertraline—MAOB—kidney—type 1 diabetes mellitus	0.00348	0.0277	CbGeAlD
Sertraline—Tension—Ramipril—type 1 diabetes mellitus	0.00347	0.0064	CcSEcCtD
Sertraline—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00346	0.00638	CcSEcCtD
Sertraline—Nervousness—Ramipril—type 1 diabetes mellitus	0.00344	0.00633	CcSEcCtD
Sertraline—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.0034	0.00627	CcSEcCtD
Sertraline—MAOA—nephron tubule—type 1 diabetes mellitus	0.00338	0.0269	CbGeAlD
Sertraline—Tremor—Ramipril—type 1 diabetes mellitus	0.00331	0.00611	CcSEcCtD
Sertraline—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00328	0.00605	CcSEcCtD
Sertraline—Agitation—Ramipril—type 1 diabetes mellitus	0.00325	0.00599	CcSEcCtD
Sertraline—Angioedema—Ramipril—type 1 diabetes mellitus	0.00323	0.00595	CcSEcCtD
Sertraline—Malaise—Ramipril—type 1 diabetes mellitus	0.00319	0.00588	CcSEcCtD
Sertraline—Vertigo—Ramipril—type 1 diabetes mellitus	0.00318	0.00586	CcSEcCtD
Sertraline—Syncope—Ramipril—type 1 diabetes mellitus	0.00317	0.00584	CcSEcCtD
Sertraline—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00317	0.00583	CcSEcCtD
Sertraline—Palpitations—Ramipril—type 1 diabetes mellitus	0.00313	0.00576	CcSEcCtD
Sertraline—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00311	0.00573	CcSEcCtD
Sertraline—Cough—Ramipril—type 1 diabetes mellitus	0.00309	0.00569	CcSEcCtD
Sertraline—Convulsion—Ramipril—type 1 diabetes mellitus	0.00307	0.00565	CcSEcCtD
Sertraline—MAOA—cardiovascular system—type 1 diabetes mellitus	0.00303	0.0241	CbGeAlD
Sertraline—Myalgia—Ramipril—type 1 diabetes mellitus	0.00301	0.00555	CcSEcCtD
Sertraline—Chest pain—Ramipril—type 1 diabetes mellitus	0.00301	0.00555	CcSEcCtD
Sertraline—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00301	0.00555	CcSEcCtD
Sertraline—Anxiety—Ramipril—type 1 diabetes mellitus	0.003	0.00553	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00299	0.00551	CcSEcCtD
Sertraline—Discomfort—Ramipril—type 1 diabetes mellitus	0.00298	0.00548	CcSEcCtD
Sertraline—MAOA—kidney—type 1 diabetes mellitus	0.00297	0.0236	CbGeAlD
Sertraline—MAOA—pancreas—type 1 diabetes mellitus	0.00295	0.0234	CbGeAlD
Sertraline—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00295	0.00543	CcSEcCtD
Sertraline—Confusional state—Ramipril—type 1 diabetes mellitus	0.00291	0.00536	CcSEcCtD
Sertraline—Oedema—Ramipril—type 1 diabetes mellitus	0.00289	0.00532	CcSEcCtD
Sertraline—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00289	0.00532	CcSEcCtD
Sertraline—Shock—Ramipril—type 1 diabetes mellitus	0.00284	0.00523	CcSEcCtD
Sertraline—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00283	0.00522	CcSEcCtD
Sertraline—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00283	0.00521	CcSEcCtD
Sertraline—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00282	0.00519	CcSEcCtD
Sertraline—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0028	0.00517	CcSEcCtD
Sertraline—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00279	0.00514	CcSEcCtD
Sertraline—Anorexia—Ramipril—type 1 diabetes mellitus	0.00275	0.00507	CcSEcCtD
Sertraline—CYP2B6—nephron tubule—type 1 diabetes mellitus	0.0027	0.0215	CbGeAlD
Sertraline—Hypotension—Ramipril—type 1 diabetes mellitus	0.0027	0.00497	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00263	0.00485	CcSEcCtD
Sertraline—Insomnia—Ramipril—type 1 diabetes mellitus	0.00261	0.00481	CcSEcCtD
Sertraline—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00259	0.00478	CcSEcCtD
Sertraline—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00257	0.00474	CcSEcCtD
Sertraline—Somnolence—Ramipril—type 1 diabetes mellitus	0.00257	0.00473	CcSEcCtD
Sertraline—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00254	0.00468	CcSEcCtD
Sertraline—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00251	0.00462	CcSEcCtD
Sertraline—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00249	0.00459	CcSEcCtD
Sertraline—Fatigue—Ramipril—type 1 diabetes mellitus	0.00249	0.00459	CcSEcCtD
Sertraline—Constipation—Ramipril—type 1 diabetes mellitus	0.00247	0.00455	CcSEcCtD
Sertraline—CYP2B6—cardiovascular system—type 1 diabetes mellitus	0.00243	0.0193	CbGeAlD
Sertraline—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.0024	0.0191	CbGeAlD
Sertraline—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00238	0.00438	CcSEcCtD
Sertraline—CYP2B6—kidney—type 1 diabetes mellitus	0.00237	0.0189	CbGeAlD
Sertraline—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00236	0.00435	CcSEcCtD
Sertraline—Urticaria—Ramipril—type 1 diabetes mellitus	0.00229	0.00423	CcSEcCtD
Sertraline—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00228	0.0042	CcSEcCtD
Sertraline—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00228	0.0042	CcSEcCtD
Sertraline—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00213	0.00392	CcSEcCtD
Sertraline—Asthenia—Ramipril—type 1 diabetes mellitus	0.00207	0.00382	CcSEcCtD
Sertraline—Pruritus—Ramipril—type 1 diabetes mellitus	0.00204	0.00376	CcSEcCtD
Sertraline—CYP2B6—lymphoid tissue—type 1 diabetes mellitus	0.00204	0.0162	CbGeAlD
Sertraline—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00198	0.00364	CcSEcCtD
Sertraline—Dizziness—Ramipril—type 1 diabetes mellitus	0.00191	0.00352	CcSEcCtD
Sertraline—Vomiting—Ramipril—type 1 diabetes mellitus	0.00184	0.00338	CcSEcCtD
Sertraline—Rash—Ramipril—type 1 diabetes mellitus	0.00182	0.00335	CcSEcCtD
Sertraline—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00182	0.00335	CcSEcCtD
Sertraline—Headache—Ramipril—type 1 diabetes mellitus	0.00181	0.00333	CcSEcCtD
Sertraline—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00179	0.0143	CbGeAlD
Sertraline—CYP3A4—kidney—type 1 diabetes mellitus	0.00179	0.0143	CbGeAlD
Sertraline—CYP2D6—kidney—type 1 diabetes mellitus	0.00176	0.014	CbGeAlD
Sertraline—Nausea—Ramipril—type 1 diabetes mellitus	0.00172	0.00316	CcSEcCtD
Sertraline—ABCB1—retina—type 1 diabetes mellitus	0.00153	0.0122	CbGeAlD
Sertraline—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00144	0.0115	CbGeAlD
Sertraline—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.0013	0.0103	CbGeAlD
Sertraline—ABCB1—kidney—type 1 diabetes mellitus	0.00127	0.0101	CbGeAlD
Sertraline—ABCB1—pancreas—type 1 diabetes mellitus	0.00126	0.01	CbGeAlD
Sertraline—MAOA—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.0012	0.00377	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	0.00119	0.00375	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—type 1 diabetes mellitus	0.00118	0.00373	CbGpPWpGaD
Sertraline—SLC6A3—Monoamine Transport—IL1B—type 1 diabetes mellitus	0.00113	0.00356	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00113	0.00355	CbGpPWpGaD
Sertraline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00112	0.00354	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.00112	0.00352	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00111	0.0035	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—type 1 diabetes mellitus	0.00111	0.0035	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—PRF1—type 1 diabetes mellitus	0.0011	0.00347	CbGpPWpGaD
Sertraline—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.00109	0.00867	CbGeAlD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—CP—type 1 diabetes mellitus	0.00108	0.00341	CbGpPWpGaD
Sertraline—SLC6A4—Monoamine Transport—TNF—type 1 diabetes mellitus	0.00107	0.00339	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00105	0.0033	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00105	0.0033	CbGpPWpGaD
Sertraline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00105	0.0033	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00104	0.00327	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000998	0.00314	CbGpPWpGaD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—STAT3—type 1 diabetes mellitus	0.000996	0.00314	CbGpPWpGaD
Sertraline—SLC6A3—Parkinsons Disease Pathway—CASP3—type 1 diabetes mellitus	0.000981	0.00309	CbGpPWpGaD
Sertraline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000979	0.00308	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—ABCC8—type 1 diabetes mellitus	0.000975	0.00307	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.000974	0.00307	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—FOXP3—type 1 diabetes mellitus	0.00097	0.00306	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.000964	0.00304	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000947	0.00298	CbGpPWpGaD
Sertraline—SLC6A2—Monoamine Transport—TNF—type 1 diabetes mellitus	0.000924	0.00291	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—GAD2—type 1 diabetes mellitus	0.000917	0.00289	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.000915	0.00288	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.000891	0.00281	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—GAD2—type 1 diabetes mellitus	0.000852	0.00268	CbGpPWpGaD
Sertraline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000836	0.00263	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000829	0.00261	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.00082	0.00258	CbGpPWpGaD
Sertraline—SLC6A3—Monoamine Transport—TNF—type 1 diabetes mellitus	0.000819	0.00258	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.000813	0.00256	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.000805	0.00254	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000803	0.00253	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000795	0.00251	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—GAD1—type 1 diabetes mellitus	0.000795	0.0025	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.00079	0.00249	CbGpPWpGaD
Sertraline—CYP1A2—Estrogen Receptor Pathway—STAT3—type 1 diabetes mellitus	0.000772	0.00243	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000771	0.00243	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000746	0.00235	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—GAD1—type 1 diabetes mellitus	0.000739	0.00233	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.000727	0.00229	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.000721	0.00227	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.000704	0.00222	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.000693	0.00218	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000682	0.00215	CbGpPWpGaD
Sertraline—CYP1A2—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000676	0.00213	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.000667	0.0021	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000652	0.00205	CbGpPWpGaD
Sertraline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000645	0.00203	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.000618	0.00195	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000604	0.0019	CbGpPWpGaD
Sertraline—CYP1A2—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.000597	0.00188	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000593	0.00187	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000592	0.00186	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.000588	0.00185	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.00055	0.00173	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.000544	0.00171	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.000529	0.00167	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000524	0.00165	CbGpPWpGaD
Sertraline—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000522	0.00164	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.000519	0.00164	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.000519	0.00164	CbGpPWpGaD
Sertraline—MAOB—Metabolism—HBA2—type 1 diabetes mellitus	0.000516	0.00163	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.000512	0.00161	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.000505	0.00159	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.000498	0.00157	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000496	0.00156	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.000494	0.00156	CbGpPWpGaD
Sertraline—MAOB—Metabolism—G6PC2—type 1 diabetes mellitus	0.000485	0.00153	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.000483	0.00152	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.000463	0.00146	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	0.00046	0.00145	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.000457	0.00144	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000453	0.00143	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000448	0.00141	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ABCC8—type 1 diabetes mellitus	0.000421	0.00133	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.000418	0.00132	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000417	0.00131	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000417	0.00131	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000416	0.00131	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000413	0.0013	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000412	0.0013	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000409	0.00129	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000409	0.00129	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000401	0.00126	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.000386	0.00122	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.000376	0.00118	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000369	0.00116	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000366	0.00115	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000349	0.0011	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000342	0.00108	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000341	0.00107	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000335	0.00106	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000334	0.00105	CbGpPWpGaD
Sertraline—MAOB—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000333	0.00105	CbGpPWpGaD
Sertraline—MAOA—Metabolism—HBA2—type 1 diabetes mellitus	0.000324	0.00102	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.000305	0.000962	CbGpPWpGaD
Sertraline—MAOA—Metabolism—G6PC2—type 1 diabetes mellitus	0.000305	0.00096	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000303	0.000954	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.0003	0.000947	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000293	0.000923	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ITPR3—type 1 diabetes mellitus	0.000281	0.000885	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.000272	0.000858	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.000272	0.000856	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.000271	0.000855	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000269	0.000849	CbGpPWpGaD
Sertraline—MAOB—Metabolism—HBA1—type 1 diabetes mellitus	0.000264	0.000833	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ABCC8—type 1 diabetes mellitus	0.000264	0.000832	CbGpPWpGaD
Sertraline—MAOB—Metabolism—APOC3—type 1 diabetes mellitus	0.000263	0.000828	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000261	0.000821	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000259	0.000818	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTT1—type 1 diabetes mellitus	0.000258	0.000813	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000255	0.000804	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000255	0.000804	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000248	0.000782	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000248	0.000781	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000244	0.00077	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000243	0.000766	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000243	0.000766	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000238	0.00075	CbGpPWpGaD
Sertraline—MAOA—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000209	0.000658	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GCG—type 1 diabetes mellitus	0.000206	0.000648	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—HBA2—type 1 diabetes mellitus	0.000203	0.000639	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000202	0.000637	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.0002	0.000631	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000199	0.000628	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000199	0.000628	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.000198	0.000622	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000191	0.000601	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000184	0.000578	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000182	0.000574	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ITPR3—type 1 diabetes mellitus	0.000176	0.000555	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000175	0.000552	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000174	0.000549	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CAT—type 1 diabetes mellitus	0.000174	0.000548	CbGpPWpGaD
Sertraline—MAOA—Metabolism—HBA1—type 1 diabetes mellitus	0.000166	0.000523	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000165	0.000521	CbGpPWpGaD
Sertraline—MAOA—Metabolism—APOC3—type 1 diabetes mellitus	0.000165	0.000519	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTT1—type 1 diabetes mellitus	0.000162	0.00051	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00016	0.000503	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	0.000153	0.000483	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.00015	0.000472	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000149	0.000469	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	0.000144	0.000454	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000141	0.000444	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000141	0.000443	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.00014	0.000441	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000136	0.00043	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000134	0.000422	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000133	0.000418	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000132	0.000415	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000131	0.000414	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000131	0.000412	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GCG—type 1 diabetes mellitus	0.000129	0.000406	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.000125	0.000394	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000122	0.000384	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000119	0.000376	CbGpPWpGaD
Sertraline—MAOB—Metabolism—INS—type 1 diabetes mellitus	0.000115	0.000364	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000115	0.000362	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000114	0.000359	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000112	0.000354	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ITPR3—type 1 diabetes mellitus	0.00011	0.000348	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CAT—type 1 diabetes mellitus	0.000109	0.000344	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ALB—type 1 diabetes mellitus	0.000106	0.000334	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—HBA1—type 1 diabetes mellitus	0.000104	0.000327	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—APOC3—type 1 diabetes mellitus	0.000103	0.000325	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000102	0.000323	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTT1—type 1 diabetes mellitus	0.000101	0.000319	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NOS3—type 1 diabetes mellitus	0.000101	0.000319	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	9.88e-05	0.000311	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	9.75e-05	0.000307	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	9.74e-05	0.000307	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	9.64e-05	0.000304	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	9.22e-05	0.000291	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	9.09e-05	0.000286	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	9.01e-05	0.000284	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	8.67e-05	0.000273	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	8.34e-05	0.000263	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	8.14e-05	0.000257	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GCG—type 1 diabetes mellitus	8.08e-05	0.000255	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	7.85e-05	0.000247	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	7.8e-05	0.000246	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	7.7e-05	0.000243	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	7.67e-05	0.000242	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	7.66e-05	0.000241	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	7.66e-05	0.000241	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	7.61e-05	0.00024	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	7.61e-05	0.00024	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	7.52e-05	0.000237	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	7.48e-05	0.000236	CbGpPWpGaD
Sertraline—MAOA—Metabolism—INS—type 1 diabetes mellitus	7.25e-05	0.000228	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	7.22e-05	0.000228	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	7.18e-05	0.000226	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	7.16e-05	0.000226	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	7.11e-05	0.000224	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.06e-05	0.000223	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	7.05e-05	0.000222	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	6.99e-05	0.00022	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	6.84e-05	0.000215	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ALB—type 1 diabetes mellitus	6.64e-05	0.000209	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.55e-05	0.000207	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	6.5e-05	0.000205	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.44e-05	0.000203	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NOS3—type 1 diabetes mellitus	6.36e-05	0.0002	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	6.12e-05	0.000193	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	6.1e-05	0.000192	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	6.08e-05	0.000192	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	5.97e-05	0.000188	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	5.96e-05	0.000188	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	5.94e-05	0.000187	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.62e-05	0.000177	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	5.57e-05	0.000175	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.5e-05	0.000173	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	5.17e-05	0.000163	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.04e-05	0.000159	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.02e-05	0.000158	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	4.76e-05	0.00015	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.75e-05	0.00015	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.72e-05	0.000149	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	4.71e-05	0.000148	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.69e-05	0.000148	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.61e-05	0.000145	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	4.54e-05	0.000143	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	4.16e-05	0.000131	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	4.03e-05	0.000127	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	3.98e-05	0.000125	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.67e-05	0.000116	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	3.43e-05	0.000108	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.35e-05	0.000105	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.16e-05	9.94e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	3.14e-05	9.91e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	3.13e-05	9.86e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.11e-05	9.79e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.07e-05	9.67e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	3.01e-05	9.48e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.94e-05	9.25e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.89e-05	9.11e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	2.87e-05	9.04e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.77e-05	8.72e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	2.74e-05	8.64e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	2.67e-05	8.42e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.45e-05	7.72e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.34e-05	7.39e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.06e-05	6.5e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.89e-05	5.96e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.81e-05	5.7e-05	CbGpPWpGaD
